Search

everythinglearnresearchcommunity

for

Search:↓

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

CTP-543 is generally safe for treating alopecia areata.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

PRP therapy can effectively treat hair loss after COVID-19 vaccination.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

The Enriched-GF method efficiently produces high-yield growth factors for tissue repair.

Plant-made bFGF helps cells grow and boosts collagen.

Third booster shots enhance the immune system's response to the COVID-19 virus.

All HPV vaccine studies should be registered and published to reduce reporting bias.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

PandaOmics uses AI to find new disease treatment targets and biomarkers.

Gene therapy in mice increased lifespan and improved health without causing cancer.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Improved finasteride formula allows slow, sustained release and better absorption for patients.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.